Catamount Wealth Management’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-100
Closed -$9K 220
2018
Q4
$9K Hold
100
0.01% 137
2018
Q3
$9K Buy
+100
New +$8.84K ﹤0.01% 149
2017
Q4
Sell
-295
Closed -$43K 219
2017
Q3
$43K Buy
295
+40
+16% +$5.45K 0.03% 84
2017
Q2
$33K Sell
255
-43,435
-99% -$5.32M 0.02% 100
2017
Q1
$5.44M Buy
43,690
+30,675
+236% +$3.67M 3.72% 8
2016
Q4
$1.51M Sell
13,015
-17,100
-57% -$1.9M 1.22% 20
2016
Q3
$3.13M Buy
30,115
+29,910
+14,590% +$3.24M 2.69% 12
2016
Q2
$20K Hold
205
0.02% 76
2016
Q1
$21K Sell
205
-801
-80% -$82.5K 0.02% 76
2015
Q4
$120K Hold
1,006
0.11% 30
2015
Q3
$109K Sell
1,006
-13,445
-93% -$1.67M 0.11% 27
2015
Q2
$1.67M Sell
14,451
-15,500
-52% -$1.77M 1.29% 23
2015
Q1
$3.45M Buy
+29,951
New +$3.58M 2.84% 14

Other funds holding CELG

Catamount Wealth Management's CELG Position: Q1 2019 in Review

Catamount Wealth Management sold out of Celgene Corp (CELG) in Q1 2019, closing a stake of 100 shares — an estimated $9K sold.

Catamount Wealth Management first reported a position in CELG in Q1 2015 and held it in 13 quarters. The position peaked at $5.44M in Q1 2017. 1,389 funds tracked by Wall St. Rank hold CELG as of Q1 2019.

  • Catamount Wealth Management reported no remaining Celgene Corp position as of Q1 2019 after selling out during the quarter.
  • Catamount Wealth Management sold 100 Celgene Corp shares in Q1 2019, an estimated $9K.
  • Catamount Wealth Management first reported a position in Celgene Corp in Q1 2015 and held it in 13 quarters.
  • Catamount Wealth Management's Celgene Corp position peaked at $5.44M in Q1 2017.
  • 1,389 funds tracked by Wall St. Rank held Celgene Corp as of Q1 2019.

Based on Catamount Wealth Management's 13F filing for Q1 2019, filed 3 May 2019.